Overview
Hannah Gendelman is a Rheumatologist in Chestnut Hill, Massachusetts. Dr. Gendelman is rated as an Experienced provider by MediFind in the treatment of Chondrocalcinosis 2. Her top areas of expertise are Dermatomyositis, Rheumatoid Arthritis (RA), Palindromic Rheumatism, and MASS Phenotype. Dr. Gendelman is currently accepting new patients.
Her clinical research consists of co-authoring 6 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
200 Boylston St, Chestnut Hill, MA 02467
330 Brookline Ave, Boston, MA 02215
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc
Irina Gavanescu-Stockton is a Rheumatologist in Boston, Massachusetts. Dr. Gavanescu-Stockton is rated as an Advanced provider by MediFind in the treatment of Chondrocalcinosis 2. Her top areas of expertise are Diffuse Idiopathic Skeletal Hyperostosis, Ankylosing Vertebral Hyperostosis with Tylosis, Gout, and Chondrocalcinosis 2. Dr. Gavanescu-Stockton is currently accepting new patients.
Brigham And Womens Physicians Organization Inc
Patricia Fraser is a Rheumatologist in Boston, Massachusetts. Dr. Fraser is rated as an Experienced provider by MediFind in the treatment of Chondrocalcinosis 2. Her top areas of expertise are Chondrocalcinosis 2, Mixed Connective Tissue Disease, MASS Phenotype, and Systemic Lupus Erythematosus (SLE). Dr. Fraser is currently accepting new patients.
Southcoast Physicians Group Inc
Ronald Rapoport is a Rheumatologist in Fall River, Massachusetts. Dr. Rapoport is rated as an Advanced provider by MediFind in the treatment of Chondrocalcinosis 2. His top areas of expertise are Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, Polymyalgia Rheumatica, and Postmenopausal Osteoporosis. Dr. Rapoport is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chondrocalcinosis 2Dr. Gendelman isExperienced. Learn about Chondrocalcinosis 2.
- DermatomyositisDr. Gendelman isExperienced. Learn about Dermatomyositis.
- MASS PhenotypeDr. Gendelman isExperienced. Learn about MASS Phenotype.
- Mixed Connective Tissue DiseaseDr. Gendelman isExperienced. Learn about Mixed Connective Tissue Disease.
- Multiple MononeuropathyDr. Gendelman isExperienced. Learn about Multiple Mononeuropathy.
- Palindromic RheumatismDr. Gendelman isExperienced. Learn about Palindromic Rheumatism.